Wanyu Cai - Betta Pharmaceuticals VP
| 300558 Stock | 49.36 3.74 7.04% |
VP
Wanyu Cai is VP of Betta Pharmaceuticals Co
| Age | 62 |
| Address | No. 355, Xingzhong Road, Hangzhou, China, 311100 |
| Phone | 86 57 1892 65665 |
| Web | https://www.bettapharma.com |
Betta Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of 0.028 % which means that it generated a profit of $0.028 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0804 %, meaning that it generated $0.0804 on every $100 dollars invested by stockholders. Betta Pharmaceuticals' management efficiency ratios could be used to measure how well Betta Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At present, Betta Pharmaceuticals' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 1.6 B, whereas Net Tangible Assets are forecasted to decline to about 2 B.Similar Executives
| Found 11 records | VP Age | ||
| Zhibin Xie | China Citic Bank | 55 | |
| Yong Cui | China Construction Bank | 55 | |
| Huaiyu Chen | Bank of China | 54 | |
| Min Zhang | China Construction Bank | 53 | |
| Gang Hu | China Citic Bank | 57 | |
| MPA CPA | China Citic Bank | 53 | |
| Yi Zhang | Agricultural Bank of | 53 | |
| Tiangui Lu | China Citic Bank | 52 | |
| Chunye Du | Postal Savings Bank | 47 | |
| Jingwu Wang | Industrial and Commercial | 58 | |
| Zhiheng Wang | Bank of China | 51 | |
Management Performance
| Return On Equity | 0.0804 | ||||
| Return On Asset | 0.028 |
Betta Pharmaceuticals Leadership Team
Elected by the shareholders, the Betta Pharmaceuticals' board of directors comprises two types of representatives: Betta Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Betta. The board's role is to monitor Betta Pharmaceuticals' management team and ensure that shareholders' interests are well served. Betta Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Betta Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hena Shi, Vice President | ||
| Jianxun Fan, CFO VP | ||
| Jiabing Wang, Chief VP | ||
| Yinxiang Wang, President | ||
| Wenxin Xu, Director Immunology | ||
| Feng Liu, Vice President | ||
| Xinshan Kang, Chief Discovery | ||
| Hao Wu, Head Director | ||
| Jiang Wan, Chief VP | ||
| Wanyu Cai, VP | ||
| Fan Jianxun, VP Officer | ||
| Lieming Ding, Chairman Founder | ||
| Yunyan Hu, Vice Center | ||
| Fuqiang Liu, VP CMC | ||
| Lingxi Wu, Independent Sec |
Betta Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Betta Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0804 | ||||
| Return On Asset | 0.028 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 22.17 B | ||||
| Shares Outstanding | 418.49 M | ||||
| Shares Owned By Insiders | 48.48 % | ||||
| Shares Owned By Institutions | 9.52 % | ||||
| Price To Book | 3.66 X | ||||
| Price To Sales | 7.49 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Betta Stock
Betta Pharmaceuticals financial ratios help investors to determine whether Betta Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Betta with respect to the benefits of owning Betta Pharmaceuticals security.